Nexgel (NXGL) Income from Continuing Operations (2018 - 2025)
Nexgel (NXGL) posted Income from Continuing Operations of 928000.0 for Q4 2025, down 43.43% on a QoQ basis from 647000.0 in Q3 2025, and down 12.62% year-over-year from 1062044.44 in Q4 2024.
Nexgel (NXGL) Income from Continuing Operations (2018 - 2025) Analysis & Trends
Nexgel's Income from Continuing Operations history runs 8 years deep, the most recent figure standing at 928000.0 for Q4 2025.
- Quarterly Income from Continuing Operations fell 12.62% year-over-year to 928000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 2893000.0 (up 16.44% YoY) and the FY2025 annual result came in at 2285000.0, up 19.06% from the prior year.
- Income from Continuing Operations was 928000.0 for Q4 2025 at Nexgel, down from 647000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 552000.0 in Q3 2023 and bottomed at 1836000.0 in Q1 2022.
- A 5-year average of 936300.0 and a median of 825000.0 in 2021 frame the typical range for Income from Continuing Operations.
- Peak annual rise in Income from Continuing Operations reached 63.29% in 2022, while the deepest fall reached 160.8% in 2022.
- Nexgel's Income from Continuing Operations stood at 1765000.0 in 2021, then soared by 63.29% to 648000.0 in 2022, then plunged by 83.18% to 1187000.0 in 2023, then jumped by 30.58% to 824000.0 in 2024, then decreased by 12.62% to 928000.0 in 2025.
- Business Quant data shows NXGL's Income from Continuing Operations at 928000.0 in Q4 2025, 647000.0 in Q3 2025, and 640000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Nexgel | 3.50 Mn | 2.13 Mn | 819,000.00 | -928,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -928,000.00 |
| Sep 30, 2025 | -647,000.00 |
| Jun 30, 2025 | -640,000.00 |
| Mar 31, 2025 | -678,000.00 |
| Dec 31, 2024 | -824,000.00 |
| Sep 30, 2024 | -754,000.00 |
| Jun 30, 2024 | -979,000.00 |
| Mar 31, 2024 | -905,000.00 |
| Dec 31, 2023 | -1.19 Mn |
| Sep 30, 2023 | -552,000.00 |
| Jun 30, 2023 | -642,000.00 |
| Mar 31, 2023 | -807,000.00 |
| Dec 31, 2022 | -648,000.00 |
| Sep 30, 2022 | -1.23 Mn |
| Jun 30, 2022 | -1.04 Mn |
| Mar 31, 2022 | -1.84 Mn |
| Dec 31, 2021 | -1.77 Mn |
| Sep 30, 2021 | -1.14 Mn |
| Jun 30, 2021 | -826,000.00 |
| Mar 31, 2021 | -704,000.00 |